NovoDermaPowered by Growth Factors

About Novo Derma

Focused solutions. Backed by science.

Novo Derma is a professional skincare brand built for the aesthetic practice — not the beauty aisle. Every formulation is powered by NovoSerum, a patented, cell-free growth-factor technology.

Who we are

A science-led aftercare company.

Novo Derma develops professional post-procedure skincare for med spas, medical spas and aesthetic practices. The brand exists to solve a specific problem: procedures that deliver the most transformative results are also the ones that create the most social downtime, and downtime is what keeps patients from booking, completing and repeating treatment.

Our approach is deliberately narrow. Rather than a broad retail range, we develop focused formulations for defined clinical moments, and we distribute them through representatives who work directly with practices on use instructions, patient materials and ordering.

The initial product

Novo Derma Post-Procedure Cream

Post-Procedure Cream is the first Novo Derma release: a single, focused formulation supplied to practices in a 1.0 oz frosted glass jar and sold in cases of six. It is used following aesthetic procedures that create downtime — CO2 and fractional laser resurfacing, microneedling, RF microneedling, microdermabrasion and chemical peels — as a cosmetic step inside a provider-directed aftercare protocol.

Additional formulations built on the same growth-factor platform will follow.

The technology

NovoSerum, the platform behind every formulation.

NovoSerum is a patented, cell-free concentrate of naturally occurring human growth factors derived from purified umbilical cord serum, sourced through a U.S.-based, FDA-regulated cord blood bank from volunteer donors after a healthy birth. It contains no stem cells and no living cells.

Growth factors are signaling proteins that communicate with fibroblasts — the cells that produce collagen and extracellular matrix during the skin’s normal repair process.

Patent protected

NovoSerum is protected under U.S. Patent No. 8,790,710 B and is the platform behind every Novo Derma formulation.

Academic research foundation

Double-blind research conducted by Dr. Robert Lavker, Director of Dermatology Research, Northwestern University Medical School.

Ethical sourcing

Umbilical cord serum sourced through a U.S.-based, FDA-regulated cord blood bank.

Read the science

Who we work with

Med spas, medical spas and aesthetic practices.

Novo Derma is sold to professional practices, not through retail channels. Our representatives work directly with a select group of practices on protocols, patient materials and ordering. If you operate an aesthetic practice and want to talk about post-procedure aftercare, we would like to hear from you.

Book a call

Regulatory position

Novo Derma Post-Procedure Cream is a cosmetic product intended to support the skin’s normal recovery process following professional aesthetic procedures. It is not a drug and is not intended to diagnose, treat, cure or prevent any disease. These statements have not been evaluated by the FDA. Patients should follow the instructions of their treating provider.